Showing results (11-20 of 11) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 11 results.
Lancet (London, England)|April 6, 2024
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trialJosé Manuel Pérez-García, Javier Cortés, Manuel Ruiz-Borrego, et al.
Pageof 2